Gilead explained that low-cost access to the drug will be delivered as a two-part strategy ... Similarly, AVAC, an ...

The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...

The Biden-Harris administration announced Monday a new requirement for insurance providers to cover injectable PrEP in their ...

Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.

The U.S Food and Drug Administration ( FDA) has confirmed the availability of lenacapavir, a two-yearly injectable HIV/ADS treatment as early as the summer 2025, a decision made by FDA after the ...

PrEP is a medication that helps prevent HIV infection ... “India’s role in the global prevention of HIV-related deaths is unmatched and laudable. However, almost 92 percent of people living with HIV ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

At issue here is a county government’s contention — despite scientific evidence to the contrary — that needle exchange ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Laura M. Mann, PhD, MPH, from the US Centers for Disease Control and Prevention in Atlanta, and colleagues used the IQVIA Real-World Longitudinal Prescription Data database (2013 to 2023) to examine ...

Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oct. 14 ...